You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 11, November 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (8)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Neuromuscular diseases
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Genetic Disorders
 •Alert me on articles by topic

Brain Morphometric Analysis in Neurofibromatosis 1

Francis J. DiMario, Jr, MD; Gale R. Ramsby, MD; Joseph A. Burleson, PhD

Arch Neurol. 1999;56:1343-1346.

Rationale and Objectives  To investigate the relationships between brain and skull base growth in patients with neurofibromatosis 1 (NF1) compared with healthy control subjects using brain magnetic resonance imaging (MRI) for morphometric analysis.

Methods  Evaluated patients included children who underwent T1- and T2-weighted or dual-echo proton density axial and T1-weighted sagittal brain MRI from January 1, 1988, to December 31, 1995. Study subjects (n=27) received a diagnosis of NF1 by accepted National Institutes of Health clinical criteria and were compared with an age- and sex-matched control group (n=43). Twenty-four predetermined ventricular and brain parenchymal dimensions and area calculations were evaluated. Data were analyzed using 2-tailed t tests, {chi}2 analysis, analysis of variance, and analysis of covariance adjusted for age and sex. Correlational analyses with respect to subject type and age were performed separately.

Results  There were 27 patients (20 boys, aged 1.0-17.7 years; mean age, 8.8 years) and 43 controls (22 boys, aged 0.1-17.7 years; mean age, 5.9 years). The mean ages between groups (boys, girls, and totals) were not statistically different. Significant differences were appreciated for 6 of 24 measures. Patients with NF1 had a significantly larger bicaudate width (P=.002), biatrial width (P<.001), and biparietal diameter (P=.003), but not hemispheric length. They also had significantly increased iter measures (P=.004), descending sigmoid sinus (P<.001), and an age-specific increase in brainstem height (P=.03) not seen in controls.

Conclusions  Patients with NF1 experience dynamic changes in brain morphometry, resulting in a predominant lateral volume expansion of the supratentorial compartment and an increasing velocity of brainstem growth as they age. These data underscore brain-region–specific parenchymal overgrowth potential.


From the Departments of Pediatrics (Dr DiMario), Radiology (Drs DiMario and Ramsby), and Behavioral Sciences and Community Health (Dr Burleson), University of Connecticut, Farmington; Connecticut Children's Medical Center, Hartford (Dr DiMario); and the University of Connecticut Health Center, Farmington (Drs DiMario, Ramsby, and Burleson).


RELATED ARTICLES

Learning Disabilities in Neurofibromatosis 1: Sizing Up the Brain
David H. Gutmann
Arch Neurol. 1999;56(11):1322-1323.
EXTRACT | FULL TEXT  

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(11):1421-1422.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

MR Imaging of the Corpus Callosum in Pediatric Patients with Neurofibromatosis Type 1
Dubovsky et al.
Am. J. Neuroradiol. 2001;22:190-195.
ABSTRACT | FULL TEXT  

Learning Disabilities in Neurofibromatosis 1: Sizing Up the Brain
Gutmann
Arch Neurol 1999;56:1322-1323.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.